Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of FLUAD-H5N1 in adults previously primed or unprimed with H5 influenza vaccines
2006-005203-33Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of Audenz in Avian Influenza (AI) (3 arms), sponsored by Novartis. Primary endpoints: Immune response after primary and booster immunization, Reactogenicity of H5N1 vaccination and 1 more. Started Nov 2006; status: completed.
02
Drugs
Audenz
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on 2006-005203-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005203-33.